Search Results - "de Weger, VA"

PCN97 - Decrease of Patient Costs in the Netherlands: a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc) by Keusters, WR, Frederix, GW, de Weger, VA, Beijnen, JH, Hövels, AM, Schellens, JH

Get full text

Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors by Hyman, D, Chatterjee, M, Langenberg, M.H.G, Lin, C.C, Suárez, C, Tai, D, Cassier, P, Yamamoto, N, De Weger, V.A, Jeay, S, Meille, C, Halilovic, E, Mariconti, L, Guerreiro, N, Kumar, A, Wuerthner, J.U, Bauer, S

“…Background: HDM201 is a potent and selective small molecule that inhibits the interaction between HDM2 and p53, leading to tumor regression in preclinical…”
Get full text

Decrease of Patient Costs in the Netherlands: a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc) by Keusters, WR, Frederix, GW, de Weger, VA, Beijnen, JH, Hövels, AM, Schellens, JH

Get full text